Richard Beasley | Academic Influence

Richard Beasley 's AcademicInfluence.com Rankings

Richard Beasley

Law

#1440

World Rank

#1816

Historical Rank

Common Law

#30

World Rank

#33

Historical Rank

Download Badge

Law

Richard Beasley 's Degrees

Bachelors Biology University of Auckland
Masters Medical Research University of New Zealand

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Richard Beasley Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Charles Richard William Beasley is a New Zealand academic physician, the founder and Director of the Medical Research Institute of New Zealand, and as of 2019 is a full professor at the Victoria University of Wellington.

(See a Problem?)

Richard Beasley 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC (1998) (3766)
The global burden of asthma: executive summary of the GINA Dissemination Committee Report (2004) (3538)
International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. (1995) (3333)
Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC) (2007) (1194)
SUBEPITHELIAL FIBROSIS IN THE BRONCHI OF ASTHMATICS (1989) (1175)
Cellular events in the bronchi in mild asthma and after bronchial provocation. (1989) (1173)
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE (2005) (1050)
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial (2018) (993)
Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. (1999) (961)
Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) (2009) (938)
Epidemiology and costs of chronic obstructive pulmonary disease (2006) (731)
Treatable traits: toward precision medicine of chronic airway diseases (2016) (707)
How much asthma is really attributable to atopy? (1999) (664)
Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC) (1997) (662)
After asthma: redefining airways diseases (2017) (649)
PRESCRIBED FENOTEROL AND DEATH FROM ASTHMA IN NEW ZEALAND, 1981-83; CASE-CONTROL STUDY (1989) (626)
Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT Randomized Clinical Trial. (2015) (576)
Prevalence and etiology of asthma. (2000) (492)
The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. (2005) (373)
Risk factors for asthma: is prevention possible? (2015) (364)
External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? (2006) (342)
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. (1991) (337)
Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. (1990) (282)
A self management plan in the treatment of adult asthma. (1989) (278)
Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6–7 years: analysis from Phase Three of the ISAAC programme (2008) (276)
Effects of cannabis on pulmonary structure, function and symptoms (2007) (259)
Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma. (2019) (253)
Cannabis use and risk of lung cancer: a case–control study (2008) (239)
Distinct clinical phenotypes of airways disease defined by cluster analysis (2009) (238)
Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis. (2001) (234)
Conservative Oxygen Therapy during Mechanical Ventilation in the ICU. (2020) (230)
Proportional classifications of COPD phenotypes (2008) (228)
Systematic review of studies of the effect of hyperoxia on coronary blood flow. (2009) (223)
Reference ranges for exhaled nitric oxide derived from a random community survey of adults. (2007) (219)
Is allergen exposure the major primary cause of asthma? (2000) (219)
The burden of asthma with specific reference to the United States. (2002) (199)
Viral respiratory tract infection and exacerbations of asthma in adult patients. (1988) (187)
The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5' monophosphate in atopic asthma. (1987) (184)
Trends in international asthma mortality: analysis of data from the WHO Mortality Database from 46 countries (1993–2012) (2017) (179)
Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. (1992) (177)
End of the New Zealand asthma mortality epidemic (1995) (177)
Routine use of oxygen in the treatment of myocardial infarction: systematic review (2008) (174)
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. (2006) (166)
Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study (2014) (162)
An audiovisual reminder function improves adherence with inhaled corticosteroid therapy in asthma. (2007) (158)
Arterial oxygen tension and mortality in mechanically ventilated patients (2011) (158)
Fast-food consumption and body mass index in children and adolescents: an international cross-sectional study (2014) (151)
The site of disruption of the bronchial epithelium in asthmatic and non-asthmatic subjects. (1992) (150)
The effect of hyperoxia following cardiac arrest - A systematic review and meta-analysis of animal trials. (2012) (149)
Is Infant Immunization a Risk Factor for Childhood Asthma or Allergy? (1997) (146)
Frequency of venous thromboembolism in low to moderate risk long distance air travellers: the New Zealand Air Traveller's Thrombosis (NZATT) study (2003) (143)
COPD prevalence in a random population survey: a matter of definition (2007) (142)
External validity of randomized controlled trials in COPD. (2007) (141)
Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial (2019) (140)
Cellular infiltration of the airways in asthma of varying severity. (1996) (140)
Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction. (1989) (140)
Perinatal factors and atopic disease in childhood (1997) (135)
Precision medicine in airway diseases: moving to clinical practice (2017) (134)
Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial. (2013) (132)
Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: ‘Swimming between the flags’* (2015) (132)
Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report (2019) (131)
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma (2005) (128)
Reduced selenium in asthmatic subjects in New Zealand. (1990) (126)
Immunization and symptoms of atopic disease in children: results from the International Study of Asthma and Allergies in Childhood. (2001) (125)
Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy (2009) (123)
The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme (2012) (122)
Comparison of a video questionnaire * with the IUATLD written questionnaire for measuring asthma prevalence (1992) (121)
International patterns of the prevalence of pediatric asthma the ISAAC program. (2003) (120)
A pilot study investigating the effects of remote ischemic preconditioning in high-risk cardiac surgery using a randomised controlled double-blind protocol (2012) (119)
The pathogenesis and significance of bronchial hyper-responsiveness in airways disease. (1987) (117)
Conservative versus Interventional Treatment for Spontaneous Pneumothorax. (2020) (115)
Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. (1989) (109)
The effect of supplemental oxygen on hypercapnia in subjects with obesity-associated hypoventilation: a randomized, crossover, clinical study. (2011) (109)
Acetaminophen use and risk of asthma, rhinoconjunctivitis, and eczema in adolescents: International Study of Asthma and Allergies in Childhood Phase Three. (2011) (106)
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation. (1985) (103)
36th International Symposium on Intensive Care and Emergency Medicine (2016) (103)
The Worldwide Association between Television Viewing and Obesity in Children and Adolescents: Cross Sectional Study (2013) (102)
Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations. (2004) (102)
β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality? (1999) (102)
eThrombosis: the 21st Century variant of venous thromboembolism associated with immobility (2003) (100)
Randomised controlled trial of high concentration versus titrated oxygen therapy in severe exacerbations of asthma (2011) (99)
Agreement between written and video questions for comparing asthma symptoms in ISAAC (2003) (98)
Aerosolized magnesium sulfate for acute asthma: a systematic review. (2005) (96)
Use of isotonic nebulised magnesium sulphate as an adjuvant to salbutamol in treatment of severe asthma in adults: randomised placebo-controlled trial (2003) (96)
Association between leukotriene receptor antagonist therapy and Churg-Strauss syndrome: an analysis of the FDA AERS database (2010) (95)
A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. (1993) (95)
Measuring the prevalence of bronchial hyper-responsiveness in children. (1995) (93)
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis (2004) (92)
Reduced selenium status of patients with asthma. (1989) (89)
The Global Lung Initiative 2012 reference values reflect contemporary Australasian spirometry (2012) (88)
The role of paracetamol in the pathogenesis of asthma (2009) (88)
Risk of Cardiovascular Events and Celecoxib: a Systematic Review and Meta-Analysis (2006) (88)
Honey in the treatment of burns: a systematic review and meta-analysis of its efficacy. (2009) (87)
Effect of oral terfenadine on the bronchoconstrictor response to inhaled histamine and adenosine 5'-monophosphate in non-atopic asthma. (1987) (87)
Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial. (2020) (86)
Venous thromboembolism following prolonged cast immobilisation for injury to the tendo Achillis. (2010) (85)
Clinical dose-response relationship of fluticasone propionate in adults with asthma. (2004) (85)
Prolonged work- and computer-related seated immobility and risk of venous thromboembolism (2010) (84)
Dose–response relationship of inhaled corticosteroids and cataracts: A systematic review and meta‐analysis (2009) (83)
Early temperature and mortality in critically ill patients with acute neurological diseases: trauma and stroke differ from infection (2015) (83)
Randomised double-blind, placebo-controlled trial of the effects of the ‘party pills’ BZP/TFMPP alone and in combination with alcohol (2010) (82)
Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. (2015) (80)
The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis (2010) (80)
Pre‐hospital oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease (2011) (79)
HyperOxic Therapy OR NormOxic Therapy after out-of-hospital cardiac arrest (HOT OR NOT): a randomised controlled feasibility trial. (2014) (78)
High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. (2012) (78)
Physiological effects of titrated oxygen via nasal high‐flow cannulae in COPD exacerbations: A randomized controlled cross‐over trial (2017) (78)
Use of cluster analysis to define COPD phenotypes (2010) (75)
Dose–response relationship for risk of non‐vertebral fracture with inhaled corticosteroids (2008) (72)
The association between BMI, vigorous physical activity and television viewing and the risk of symptoms of asthma, rhinoconjunctivitis and eczema in children and adolescents: ISAAC Phase Three (2013) (71)
Adverse reactions to the non-drug constituents of nebuliser solutions. (1988) (69)
International trends in asthma mortality. (1997) (69)
Role of bronchial responsiveness testing in asthma prevalence surveys (2000) (67)
Smoking and COPD: what really are the risks? (2006) (66)
Quality of life measured by the St George's Respiratory Questionnaire and spirometry (2009) (65)
The magnitude of the effect of smaller family sizes on the increase in the prevalence of asthma and hay fever in the United Kingdom and New Zealand. (1999) (65)
Use of metered-dose inhaler electronic monitoring in a real-world asthma randomized controlled trial. (2013) (65)
The risk of serious adverse outcomes associated with hypoxaemia and hyperoxaemia in acute exacerbations of COPD (2012) (64)
The effects of early and late paracetamol exposure on asthma and atopy: a birth cohort (2011) (63)
Association of asthma therapy and Churg-Strauss syndrome: an analysis of postmarketing surveillance data. (2004) (62)
Accuracy of patient self‐report as a measure of inhaled asthma medication use (2013) (62)
A systematic review and meta-analysis of the cardioprotective effects of remote ischaemic preconditioning in open cardiac surgery (2012) (62)
Case-control study of salmeterol and near-fatal attacks of asthma. (1998) (61)
Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome. (2013) (61)
The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. (2001) (60)
Predictive value of blood eosinophils and exhaled nitric oxide in adults with mild asthma: a prespecified subgroup analysis of an open-label, parallel-group, randomised controlled trial. (2020) (59)
Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease (2015) (59)
Combination corticosteroid/β-agonist inhaler as reliever therapy: a solution for intermittent and mild asthma? (2014) (57)
Predictors of severe exacerbations, poor asthma control, and β-agonist overuse for patients with asthma. (2014) (57)
International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. (2009) (56)
Beta agonists and asthma mortality: déjà vu (1992) (56)
A systematic review of the accuracy of peripheral thermometry in estimating core temperatures among febrile critically ill patients. (2011) (55)
Metrics of salbutamol use as predictors of future adverse outcomes in asthma (2013) (55)
Cannabis use and cancer of the head and neck: Case-control study (2008) (54)
Time to define the disorders of the syndrome of COPD (2009) (54)
Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. (2019) (54)
Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? (1999) (53)
Efficacy of bupropion in the indigenous Maori population in New Zealand (2005) (53)
Asthma mortality and inhaled beta agonist therapy. (1991) (52)
Pathology of asthma and its clinical implications. (1993) (52)
Association between Frequency of Consumption of Fruit, Vegetables, Nuts and Pulses and BMI: Analyses of the International Study of Asthma and Allergies in Childhood (ISAAC) (2018) (51)
The relationship between FEV1 and PEF in the assessment of the severity of airways obstruction (2002) (51)
Safety of long-acting β-agonists: urgent need to clear the air remains (2009) (51)
Supplementary oxygen for nonhypoxemic patients: O2 much of a good thing? (2011) (51)
Acetaminophen for Fever in Critically Ill Patients with Suspected Infection. (2016) (51)
Asthma exacerbations · 5: Assessment and management of severe asthma in adults in hospital (2007) (50)
Paracetamol in pregnancy and the risk of wheezing in offspring: a systematic review and meta‐analysis (2011) (50)
Childhood asthma and GOLD‐defined chronic obstructive pulmonary disease (2012) (49)
Conservative oxygen therapy for mechanically ventilated adults with sepsis: a post hoc analysis of data from the intensive care unit randomized trial comparing two approaches to oxygen therapy (ICU-ROX) (2019) (49)
Serum periostin in obstructive airways disease (2016) (49)
Trial of a "credit card" asthma self-management plan in a high-risk group of patients with asthma. (1996) (49)
Systematic review of the dose-response relation of inhaled fluticasone propionate (2004) (48)
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial (2021) (48)
Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. (2015) (47)
Seasonal variation in asthma hospitalizations and death rates in New Zealand (2000) (47)
Respiratory syncytial virus: paying the immunity debt with interest (2021) (47)
The self-administration of inhaled beta agonist drugs during severe asthma. (1990) (47)
The contribution of histamine release to bronchoconstriction provoked by inhaled benzalkonium chloride in asthma. (1988) (47)
Airway remodelling in asthma (2002) (46)
The rise and rise of asthma: a new paradigm for the new millennium? (2000) (46)
Inhaled fluticasone propionate and adrenal effects in adult asthma: systematic review and meta-analysis (2006) (46)
Confounding by severity does not explain the association between fenoterol and asthma death (1994) (46)
Use of a management plan for treating asthma in an emergency department. (1990) (45)
An inverse correlation between estimated tuberculosis notification rates and asthma symptoms (2002) (45)
The use of a videotaped questionnaire for studying asthma prevalence. A pilot study among New Zealand adolescents. (1992) (44)
Utility of lung density measurements in the diagnosis of emphysema. (2007) (44)
Oxygen therapy in myocardial infarction: an historical perspective. (2007) (44)
Acetaminophen use and risk of asthma, rhinoconjunctivitis and eczema in adolescents : ISAAC Phase Three (2010) (44)
Cardiovascular effects of fenoterol under conditions of hypoxaemia. (1992) (44)
Fenoterol and Death from Asthma in New Zealand. (1992) (43)
Evaluation of patients’ experiences at different stages of the intravitreal injection procedure – what can be improved? (2011) (43)
Seasonal Variation in Asthma-Related Hospital and Intensive Care Unit Admissions (2005) (41)
Prolonged seated immobility at work is a common risk factor for venous thromboembolism leading to hospital admission (2008) (41)
Sleep disorders: a potential role in New Zealand motor vehicle accidents (2002) (41)
A case–control study of seated immobility at work as a risk factor for venous thromboembolism (2008) (41)
The all‐age spirometry reference ranges reflect contemporary Australasian spirometry (2011) (41)
Effect of repeated intradermal injections of heat‐inactivated Mycobacterium bovis bacillus Calmette–Guérin in adult asthma (2004) (41)
Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol. (1996) (41)
Long-term reduction in asthma morbidity following an asthma self-management programme. (1998) (40)
The association between early arterial oxygenation and mortality in ventilated patients with acute ischaemic stroke. (2012) (40)
Increased risk of cardiovascular events with parecoxib/valdecoxib: a systematic review and meta-analysis. (2005) (40)
Cumulative and single-dose design to assess the bronchodilator effects of beta2-agonists in individuals with asthma. (2001) (40)
Kanuka honey versus aciclovir for the topical treatment of herpes simplex labialis: a randomised controlled trial (2019) (39)
Preservatives in Nebulizer Solutions: Risks without Benefit (1998) (39)
Call for withdrawal of LABA single-therapy inhaler in asthma (2010) (39)
Randomized controlled trial of high concentration oxygen in suspected community-acquired pneumonia (2012) (39)
The pulmonary and extrapulmonary effects of inhaled β‐agonists in patients with asthma (1990) (39)
Understanding the true burden of COPD: the epidemiological challenges. (2012) (38)
Influenza control during the COVID-19 pandemic (2020) (38)
Risk of mortality associated with formoterol: a systematic review and meta-analysis (2009) (38)
Cholinergic-Mediated Bronchoconstriction Induced by Prostaglandin D2, Its Initial Metabolite 9α, 11β-PGF2, and PGF2α in Asthma (1987) (38)
Six-month in vitro validation of a metered-dose inhaler electronic monitoring device: implications for asthma clinical trial use. (2012) (38)
Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma. (2010) (37)
Prescribed drug therapy and near-fatal asthma attacks. (1994) (37)
The multiple dimensions of airways disease: targeting treatment to clinical phenotypes (2011) (37)
The risk of asthma mortality with inhaled long acting β-agonists (2008) (37)
The role of histamine in allergen and adenosine-induced bronchoconstriction. (1987) (36)
Budesonide once versus twice‐daily administration: meta‐analysis (2004) (36)
The value of the CRB65 score to predict mortality in exacerbations of COPD requiring hospital admission (2011) (36)
Systematic review and meta-analysis of the risk of major cardiovascular events with etoricoxib therapy. (2005) (36)
Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution. (1988) (36)
Underestimation of COVID-19 mortality during the pandemic (2020) (36)
Reference ranges for serum periostin in a population without asthma or chronic obstructive pulmonary disease (2016) (36)
Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use (2015) (36)
Hospital admissions for non-cystic fibrosis bronchiectasis in New Zealand. (2015) (36)
Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study. (2011) (35)
Problems of measuring asthma prevalence (1996) (35)
The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation. (1990) (35)
Complete reference ranges for pulmonary function tests from a single New Zealand population. (2006) (35)
The influence of ipratropium bromide and sodium cromoglycate on benzalkonium chloride-induced bronchoconstriction in asthma. (1988) (34)
High blood pressure advice given by natural health food stores. (2009) (34)
Sing Your Lungs Out—a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study (2017) (34)
Poppy seed tea and opiate abuse in New Zealand. (2007) (33)
The acetaminophen and asthma hypothesis 10 years on: A case to answer. (2009) (33)
Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. (1992) (32)
Call for worldwide withdrawal of tiotropium Respimat mist inhaler (2012) (32)
Biologic pollution in infant bedding in New Zealand: high allergen exposure during a vulnerable period. (1998) (32)
Selenium, glutathione peroxidase and asthma (1991) (32)
Asthma morbidity 6 yrs after an effective asthma self-management programme in a Maori community. (2000) (32)
Asthma deaths in New Zealand. (1992) (31)
The use of the self-management plan system of care in adult asthma. (2004) (31)
Is it time to change the approach to oxygen therapy in the breathless patient? (2007) (31)
A Two Centre Observational Study of Simultaneous Pulse Oximetry and Arterial Oxygen Saturation Recordings in Intensive Care Unit Patients (2018) (31)
Hospital admissions for chronic obstructive pulmonary disease in New Zealand. (2015) (31)
The use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysis (2015) (31)
A protocol for the 0.9% saline versus Plasma-Lyte 148 for intensive care fluid therapy (SPLIT) study. (2014) (31)
Geographical variation in the prevalence of asthma symptoms in New Zealand. (1997) (30)
Use of peak flow-based self-management plans by adult asthmatic patients. (1996) (30)
A study of New Zealand wood workers: exposure to wood dust, respiratory symptoms, and suspected cases of occupational asthma. (1992) (30)
The asthma self-management plan system of care: what does it mean, how is it done, does it work, what models are available, what do patients want and who needs it? (1997) (29)
Bronchial gland duct ectasia in fatal bronchial asthma: association with interstitial emphysema. (1989) (29)
Asthma and allergy: a worldwide problem of meanings and management? (2002) (29)
Randomised controlled crossover trial of the effect on Ptco2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease (2011) (29)
Study protocol for a randomised controlled trial of invasive versus conservative management of primary spontaneous pneumothorax (2016) (28)
An audit of the effect of oxygen prescription charts on clinical practice (2010) (28)
SIT (seated immobility thromboembolism) syndrome: a 21st century lifestyle hazard. (2005) (28)
The New Zealand national junior doctors' strike: implications for the provision of acute hospital medical services. (2008) (28)
Assessing PaCO2 in acute respiratory disease: accuracy of a transcutaneous carbon dioxide device (2011) (28)
Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial (2018) (27)
Conservative oxygen therapy for mechanically ventilated adults with suspected hypoxic ischaemic encephalopathy (2020) (27)
Fever control in critically ill adults. An individual patient data meta-analysis of randomised controlled trials (2019) (27)
The effect of an increase in inhaled allergen dose after terfenadine on the occurrence and magnitude of the late asthmatic response (1989) (27)
Prospective observational study in patients with obstructive lung disease: NOVELTY design (2019) (27)
New look at the oxyhaemoglobin dissociation curve (2006) (27)
Leukotriene receptor antagonist therapy and Churg–Strauss syndrome: culprit or innocent bystander? (2008) (26)
Association between breastfeeding and body mass index at age 6–7 years in an international survey (2015) (26)
Target oxygen saturation range: 92–96% Versus 94–98% (2017) (26)
High-concentration oxygen therapy in COPD (2011) (26)
Overview of the study protocols and statistical analysis plan for the Saline versus Plasma-Lyte 148 for Intravenous Fluid Therapy (SPLIT) research program. (2015) (26)
ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis (2021) (26)
Primary and secondary effector cells in the pathogenesis of bronchial asthma. (1987) (26)
Tiotropium Respimat increases the risk of mortality (2012) (26)
Use of near fatal asthma for investigating asthma deaths. (1993) (25)
Optimal Asthma Control: Time for a New Target. (2020) (25)
Asthma and Respiratory Foundation NZ adult asthma guidelines: a quick reference guide. (2016) (25)
A multicentre prospective observational study comparing arterial blood gas values to those obtained by pulse oximeters used in adult patients attending Australian and New Zealand hospitals (2020) (24)
The pulmonary and extra‐pulmonary effects of high‐dose formoterol in COPD: A comparison with salbutamol (2004) (24)
Type 2 Biomarkers and Prediction of Future Exacerbations and Lung Function Decline in Adult Asthma. (2018) (24)
Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort (2021) (23)
Lack of evidence for beta-2 receptor selectivity: a study of metaproterenol, fenoterol, isoproterenol, and epinephrine in patients with asthma. (1991) (23)
Merino wool graduated compression stocking increases lower limb venous blood flow: A randomized controlled trial (2011) (23)
Randomised controlled trial of topical kanuka honey for the treatment of rosacea (2013) (23)
Opinions and practice of stress ulcer prophylaxis in Australian and New Zealand intensive care units. (2014) (23)
Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial (2015) (23)
The further paradoxes of asthma management: time for a new approach across the spectrum of asthma severity (2018) (23)
Reduction of the Cardiovascular Effects of Inhaled Fenoterol by Use of a Valved Holding Chamber Device (1989) (23)
Delivery of titrated oxygen via a self-inflating resuscitation bag. (2013) (23)
Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus (2016) (23)
Limited generalisability of UPLIFT findings to clinical practice (2013) (23)
Treatable traits of chronic airways disease (2018) (22)
Prevalence of asthma symptoms among adolescents in the Wellington region, by area and ethnicity. (1993) (22)
Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma. (2010) (22)
Trial of an asthma action plan in the Maori community of the Wairarapa. (1993) (22)
Asthma and the beta agonist debate. (1995) (22)
Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma (2020) (22)
Early peak temperature and mortality in critically ill patients with or without infection (2011) (22)
β-agonist therapy and asthma mortality in Japan (1998) (22)
Bronchodilator responsiveness: interpret with caution (2012) (22)
Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use (2016) (22)
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma (2020) (22)
A hypothesis to phenotype COPD exacerbations by aetiology (2011) (22)
Oxygen therapy in myocardial infarction: an historical perspective (2007) (21)
Asthma: Time to confront some inconvenient truths (2010) (21)
Short-acting β-agonist use as a marker of current asthma control. (2013) (21)
Description of a randomised controlled trial of inhaled corticosteroid/fast-onset LABA reliever therapy in mild asthma (2016) (21)
Albuterol and deaths from asthma in New Zealand from 1969 to 1976: A case‐control study (1992) (21)
Is Enhanced Fetal Growth a Risk Factor for the Development of Atopy or Asthma? (1999) (21)
Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma (2014) (21)
Oxygenation targets, monitoring in the critically ill: a point prevalence study of clinical practice in Australia and New Zealand. (2015) (21)
The HEAT trial: a protocol for a multicentre randomised placebo-controlled trial of IV paracetamol in ICU patients with fever and infection. (2012) (21)
Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial (2018) (20)
Factors associated with body mass index in children and adolescents: An international cross-sectional study (2018) (20)
Use of nebulised magnesium sulphate as an adjuvant in the treatment of acute exacerbations of COPD in adults: a randomised double-blind placebo-controlled trial (2013) (20)
Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9α, 11β‐PGF2 in human skin (1988) (20)
Withdrawal of fenoterol and the end of the New Zealand asthma mortality epidemic. (1995) (19)
Has the role of atopy in the development of asthma been over‐emphasized? (2001) (19)
Occupational Risk Factors for Chronic Respiratory Disease in a New Zealand Population Using Lifetime Occupational History (2014) (19)
Fluticasone given once versus twice a day: Meta‐analysis (2005) (19)
Metered dose inhalers: A need for dose counters (2005) (19)
Patient preferences for symptom-driven or regular preventer treatment in mild to moderate asthma: findings from the PRACTICAL study, a randomised clinical trial (2020) (19)
Immunopathology of fatal soybean dust-induced asthma. (1996) (18)
A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. (1993) (18)
Trends in asthma mortality in New Zealand, 1908–1986 (1990) (18)
Venous thromboembolism risk associated with protracted work- and computer-related seated immobility: A case-control study (2016) (18)
Comparative studies of inhaled corticosteroids in asthma. (2001) (18)
Longitudinal variation of serum periostin levels in adults with stable asthma. (2017) (18)
A historical perspective of the New Zealand asthma mortality epidemics. (2006) (18)
Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: a randomized, controlled, proof-of-activity trial. (2021) (18)
Inhaled corticosteroids in acute asthma: A systemic review and meta-analysis. (2020) (18)
The association between paracetamol use and asthma: causation or coincidence? (2015) (17)
Asthma morbidity and mortality in New Zealand. (1995) (17)
A study of the management of asthma in a hospital emergency department. (1989) (17)
The 24 h duration of bronchodilator action of the salmeterol/fluticasone combination inhaler. (2005) (16)
Comparison of potency of inhaled beclomethasone and budesonide in New Zealand: retrospective study of computerised general practice records (1998) (16)
Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections (2011) (16)
Physiological associations of computerized tomography lung density: a factor analysis (2006) (16)
Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. (2022) (16)
Tiotropium Respimat increases the risk of mortality: pro (2013) (16)
Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial (2018) (16)
Comparative audit of oxygen use in the prehospital setting in acute COPD exacerbation over 5 years (2013) (16)
Towards individualised treatment in COPD (2011) (16)
Magnesium in the treatment of asthma (2007) (16)
Birth weight and subsequent body mass index in children: an international cross‐sectional study (2017) (16)
Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma. (2016) (15)
Pilot study of the safety and effect of intranasal delipidated acid‐treated Mycobacterium vaccae in adult asthma (2003) (15)
Effect of active temperature management on mortality in intensive care unit patients. (2018) (15)
British National Formulary for Children: the risk of inappropriate paracetamol prescribing (2011) (15)
β2-agonists in asthma (1991) (15)
Randomized controlled trial of the effect of regular paracetamol on influenza infection (2015) (15)
Fenoterol, asthma deaths, and asthma severity. (1997) (15)
A comparison of the extent and duration of hypokalaemia following three nebulized beta2-adrenoceptor agonists (2004) (14)
Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma (2017) (14)
Bronchoconstriction induced by nebulised ipratropium bromide: relation to the bromide ion. (1986) (14)
Asthma and Allergies in Childhood (ISAAC) symptoms: phase III of the International Study of Worldwide trends in the prevalence of asthma (2007) (14)
Recent air travel and venous thromboembolism resulting in hospital admission (2006) (14)
Reducing asthma mortality with the asthma self-management plan system of care. (2001) (14)
Raised plasma homocysteine levels in alcoholism: increasing the risk of heart disease and dementia? (2005) (14)
Change in biomarkers of type-2 inflammation following severe exacerbations of asthma (2018) (14)
Lower limb immobilisation and venous thromboembolism risk: combined case–control studies (2016) (14)
Do natural health food stores require regulation? (2002) (14)
Prescribing for childhood asthma in the Wellington area: comparison with international guidelines. (1993) (13)
Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma. (1987) (13)
How big is your bubble? Characteristics of self-isolating household units (‘bubbles’) during the COVID-19 Alert Level 4 period in New Zealand: a cross-sectional survey (2021) (13)
Effect of sitting in ergonomic chairs on lower limb venous blood flow. (2009) (13)
The Bronchoconstrictor Activity of Adenosine in Asthma (1987) (13)
Specific oral contraceptive use and venous thromboembolism resulting in hospital admission. (2004) (13)
Intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX): results of the pilot phase. (2017) (13)
Telemedicine for management of patients with COPD (2009) (13)
Determinants of plasma D‐dimer levels in a traveling population (2005) (13)
Lung cancer in Maori: a neglected priority. (2005) (13)
Effect of 0.9% Saline or Plasma-Lyte 148 as Crystalloid Fluid Therapy in the Intensive Care Unit on Blood Product Use and Postoperative Bleeding After Cardiac Surgery. (2017) (12)
Nasal high‐flow therapy compared with non‐invasive ventilation in COPD patients with chronic respiratory failure: A randomized controlled cross‐over trial (2019) (12)
A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. (2018) (12)
Randomised controlled trial of topical kanuka honey for the treatment of acne (2016) (12)
Are Environmental Factors for Atopic Eczema in ISAAC Phase Three due to Reverse Causation? (2019) (12)
High flow or titrated oxygen for obese medical inpatients: a randomised crossover trial (2017) (12)
Fever and antipyresis in infection (2011) (12)
The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler. (2006) (12)
The effect of high concentration oxygen therapy on PaCO2 in acute and chronic respiratory disorders (2013) (12)
Association between early peak temperature and mortality in neutropenic sepsis (2015) (12)
Effect of smoking status on the efficacy of the SMART regimen in high risk asthma (2016) (12)
Day-time variation of serum periostin in asthmatic adults treated with ICS/LABA and adults without asthma (2017) (12)
Protocol summary and statistical analysis plan for the intensive care unit randomised trial comparing two approaches to oxygen therapy (ICU-ROX). (2018) (11)
Asthma and the β agonist debate (1995) (11)
The effect of hypercapnia and hypoxemia on the cardiovascular responses to isoproterenol (1994) (11)
After asthma – redefining airways diseases. A Lancet commission (2017) (11)
Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting (2017) (11)
Patient preferences for asthma management: a qualitative study (2020) (11)
Medical cannabis: knowledge and expectations in a cohort of North Island New Zealand general practitioners. (2020) (11)
The dose-response relationship of inhaled corticosteroids in asthma (2004) (11)
Body mass index and vigorous physical activity in children and adolescents: an international cross‐sectional study (2017) (11)
Preservatives in Nebulizer Solutions: Risks without Benefit—A Further Comment (1999) (11)
Acute use of oxygen therapy. (2015) (10)
New hospital consultant: surviving a difficult period. (2007) (10)
The international asthma video questionnaire for measuring asthma prevalence in different populations. (1995) (10)
Chemical and physical variations of cannabis smoke from a variety of cannabis samples in New Zealand (2018) (10)
Venous thromboembolism rates in patients with lower limb immobilization after Achilles tendon injury are unchanged after the introduction of prophylactic aspirin: audit (2016) (10)
Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults (2014) (10)
The management of mild asthma (2020) (10)
Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine (2016) (10)
Maternal post-natal tobacco use and current parental tobacco use is associated with higher body mass index in children and adolescents: an international cross-sectional study (2015) (10)
Efficacy of Micromobile Foot Compression Device in Increasing Lower Limb Venous Blood Flow (2013) (10)
Statistical analysis plan for the HEAT trial: a multicentre randomised placebo-controlled trial of intravenous paracetamol in intensive care unit patients with fever and infection. (2013) (10)
Randomised controlled trial of topical kanuka honey for the treatment of cold sores (2014) (10)
Beta-agonist therapy and asthma mortality in Japan. (1998) (9)
Review: Should ethanol be scheduled as a drug of high risk to public health? (2009) (9)
A multicentre feasibility study evaluating stress ulcer prophylaxis using hospital-based registry data. (2014) (9)
Avoidance of high concentration oxygen in chronic obstructive pulmonary disease (2010) (9)
Hemochromatosis gene mutations, liver function tests and iron status in alcohol‐dependent patients admitted for detoxification (2007) (9)
Patient experiences of as-needed budesonide-formoterol by Turbuhaler® for treatment of mild asthma; a qualitative study. (2020) (9)
From medical student to junior doctor: The medical handover - a good habit to cultivate (2006) (9)
Neopterin quantification in acute severe asthma (1991) (9)
The effect of benzalkonium chloride on the bronchodilator response to salbutamol nebuliser solution. (1990) (9)
Randomized controlled trial of asthma risk with paracetamol use in infancy – a feasibility study (2015) (9)
Re: "Confounding by indication and channeling over time: the risks of beta2-agonists". (1997) (9)
Serum periostin levels in adults of Chinese descent: an observational study (2018) (9)
Balancing the needs of the many and the few: where next for adult asthma guidelines? (2021) (9)
Phenotypes of symptomatic airways disease in China and New Zealand (2017) (9)
Beta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trial (2017) (8)
Long-Acting Beta-Agonists and Asthma Death: How Useful Are Different Study Designs to Evaluate the Potential Association? (2010) (8)
A randomised controlled trial of topical Kanuka honey for the treatment of psoriasis (2014) (8)
Tolerability of Nasal Delivery of Humidified and Warmed Air at Different Temperatures: A Randomised Double-Blind Pilot Study (2016) (8)
The effect of the increased prescription charges on the collection of asthma drugs. (1992) (8)
Inhaled magnesium sulfate in the treatment of acute asthma. (2012) (8)
The cardiovascular effects of inhaled fenoterol alone and during treatment with oral theophylline. (1989) (8)
Duration of action of the salmeterol/fluticasone combination inhaler administered in the evening: A randomized controlled trial in childhood asthma (2006) (8)
Epidemiology of Asthma Mortality (2009) (8)
Asthma following royal jelly. (1996) (8)
Serum periostin levels following small bone fractures, long bone fractures and joint replacements: an observational study (2018) (8)
Towards the optimal use of inhaled corticosteroid therapy in adult asthma. (2001) (8)
Unmet need in inadequately controlled asthma (2007) (8)
Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial. (2019) (8)
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE) (2021) (8)
A man who collapsed after using the internet (2014) (8)
Gaming: a 21st century variant of seated immobility thromboembolism. (2018) (7)
Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease (2007) (7)
Reducing the burden of asthma: time to set research and clinical priorities. (2020) (7)
An audit of pulmonary rehabilitation program (2016) (7)
Pulmonary function testing in New Zealand: The use and importance of reference ranges (2007) (7)
Obesity, underweight and BMI distribution characteristics of children by gross national income and income inequality: results from an international survey (2018) (7)
Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma (2022) (7)
Using comics and curiosity to drive pandemic research on a national scale (2020) (7)
Inflammatory Processes in Bronchial Asthma (2012) (7)
The New Zealand asthma mortality epidemic. (1996) (7)
Increasing compliance with inhaled corticosteroids through the use of combination therapy. (2004) (7)
A review of the studies of the asthma mortality epidemic in New Zealand. (1995) (6)
The diagnostic role of ventilation/perfusion scans versus computed tomography pulmonary angiography in obstetric patients investigated for pulmonary embolism at Wellington Hospital from 2010 to 2012. (2016) (6)
Letting the right one in: evaluating the generalisability of clinical trials (2018) (6)
Incidental findings from lung CT scans: Implications for research (2011) (6)
Inhaled Corticosteroid Therapy in the Management of Asthma in Adults: Leukotriene Modifiers (2005) (6)
The statistical analysis plan for the 0 . 9 % Saline vs . Plasma-Lyte 148 ® for Intensive care fluid Therapy ( SPLIT ) study (2014) (6)
The Role of Beta Receptor Agonist Therapy in Asthma Mortality (1993) (6)
Fenoterol and asthma mortality (1990) (6)
End of New Zealand asthma epidemic (1995) (6)
Worldwide worsening wheezing—is the cure the cause? (1992) (6)
Effect of saline 0.9% or Plasma-Lyte 148 therapy on feeding intolerance in patients receiving nasogastric enteral nutrition. (2016) (6)
The relationship between pulmonary interstitial emphysema and clinical features in fatal asthma. (1994) (6)
BENZALKONIUM CHLORIDE AND BRONCHOCONSTRICTION (1986) (6)
Towards a personalised treatment approach for asthma attacks (2020) (6)
A randomised controlled trial of the effect of high concentration oxygen on myocardial ischaemia during exercise. (2012) (6)
Fixed and adjustable dose asthma action plans based on combination therapy: A pilot study (2005) (6)
The history and future of short‐acting beta2‐agonist therapy in asthma (2019) (6)
Asthma and Respiratory Foundation NZ Adolescent and Adult Asthma Guidelines 2020: a quick reference guide. (2020) (6)
Experiences, patient interactions and knowledge regarding the use of cannabis as a medicine in a cohort of New Zealand doctors in an oncology setting (2020) (6)
Restriction of LABA use to combination ICS/LABA inhaler therapy in asthma (2012) (6)
Proposed MHRA changes to UK children's paracetamol dosing recommendations: modelling study (2012) (6)
Effect of EDTA on the bronchodilator response to Duovent nebuliser solution. (1989) (6)
The inhaled corticosteroid/long-acting β-agonist maintenance and reliever therapy regimen: where to from here? (2018) (6)
Beta-agonists and death from asthma. (1992) (6)
Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma? (2013) (6)
Measuring morbidity in adult asthmatics. (1999) (6)
SMART for the treatment of asthma: A network meta-analysis of real-world evidence. (2021) (6)
Rhinovirus is not detectable in peripheral lung tissue after asthma death (2003) (6)
Methotrexate in Asthma (1993) (5)
Engaging Māori with qualitative healthcare research using an animated comic. (2020) (5)
Paracetamol as a risk factor for allergic disorders – Authors' reply (2009) (5)
PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'. (2005) (5)
RANGES FOR SERUM PERIOSTIN IN A POPULATION WITHOUT ASTHMA OR COPD (2016) (5)
Oxygen: a new look at an old therapy (2019) (5)
Asthma in New Zealand--time to get control. (2003) (5)
Asthma deaths in New Zealand: Author's reply (1992) (5)
Comparative vascular effects of histamine, prostaglandin (PG) D2 and its metabolite 9 alpha,11 beta-PGF2 in human skin. (1988) (5)
Treatable traits in the NOVELTY study (2022) (5)
Management of asthma in the hospital emergency department. (1996) (5)
Budesonide–formoterol reliever therapy in intermittent versus mild persistent asthma (2020) (5)
The airways effects of inhaled chlorbutol in asthmatic subjects. (1990) (5)
β-Agonist Use and Death from Asthma (1994) (5)
Randomised controlled trial of rhinothermy for treatment of the common cold: a feasibility study (2018) (5)
Association between paracetamol use in infancy or childhood with body mass index (2015) (5)
Randomised evaluation of active control of temperature versus ordinary temperature management (REACTOR) trial (2017) (5)
Towards individualised medicine for airways disease: identifying clinical phenotype groups (2012) (5)
Thoracic Society of Australia and New Zealand Position Statement on Acute Oxygen Use in Adults: ‘Swimming between the flags’ (2022) (5)
What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment (2020) (5)
The mediator and cellular basis of the allergic response (1988) (5)
Closed-Loop Oxygen Control Using a Novel Nasal High-Flow Device: A Randomized Crossover Trial (2020) (5)
Potential Association Between Dietary Fibre and Humoral Response to the Seasonal Influenza Vaccine (2021) (5)
RESPIRATORY ARREST IN NEAR-FATAL ASTHMA. REPLY (1991) (5)
What risks do women face when seeking advice during pregnancy from pharmacies and natural health retailers? (2012) (5)
From medical student to junior doctor : maintaining good health during the “baptism of fire” (2006) (5)
Asthma and COVID-19: Preconceptions about Predisposition (2021) (5)
Nasal gene expression changes with inhaled corticosteroid treatment in asthma (2020) (4)
Frequency of dosing and comparative doses of mometasone furoate: A meta‐analysis (2009) (4)
A Randomised Controlled Double-Blind Study of Remote Ischaemic Preconditioning in High-Risk Cardiac Surgery (2013) (4)
Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial (2020) (4)
Cohort study of a simple ‘Step‐Up’ regimen with the Asthma Control Test (2015) (4)
Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling (2022) (4)
Automatic versus manual oxygen titration using a novel nasal high-flow device in medical inpatients with an acute illness: a randomised controlled trial (2021) (4)
Cohort feasibility study of an intermittent pneumatic compression device within a below-knee cast for the prevention of venous thromboembolism (2016) (4)
Audit of oxygen administration to achieve a target oxygen saturation range in acutely unwell medical patients (2021) (4)
Fenoterol, asthma deaths, and asthma severity: confounding or confusion? (1997) (4)
What to do at step 3 of the asthma guidelines-increase the dose of inhaled corticosteroids or add a long-acting beta-agonist drug? (2003) (4)
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma (2019) (4)
One name to rule them all, one name to find them: Lord of the Rings and 'seated immobility thromboembolism (SIT) syndrome'. (2003) (4)
Antipyretic therapy for influenza infection--benefit or harm? (2011) (4)
Increased risk of mortality with liberal oxygen therapy compared with conservative oxygen therapy in critically ill adults (2018) (4)
A half doubling dose change in bronchial hyperresponsiveness in a population represents an important difference (2013) (4)
Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial (2022) (4)
Knowledge and perspectives about the use of cannabis as a medicine: a mixed methods observational study in a cohort of New Zealand general practice patients. (2020) (4)
β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial (2017) (4)
Bronchial diverticulitis: complication of bronchial asthma. (1988) (4)
Beta agonists and asthma mortality: déjà vu (1991) (4)
COX-2 inhibitors--first, do no harm. (2005) (4)
The effect of 1g of acetaminophen twice daily for 12 weeks on alanine transaminase levels--A randomized placebo-controlled trial. (2015) (4)
Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid (2014) (3)
Anti‐inflammatory reliever therapy in asthma: The evidence mounts but more is needed (2020) (3)
Remote ischaemic preconditioning does not alter perioperative cytokine production in high-risk cardiac surgery (2012) (3)
ISOPRENALINE, FENOTEROL AND ASTHMA DEATHS IN JAPAN (1997) (3)
Public engagement with clinical research on social media; which visual medium works best? A 5-year retrospective analysis (2021) (3)
Seasonal distribution of episodes of acute severe asthma in adults (1997) (3)
Triaging treatable traits in asthma (2018) (3)
Inconsistencies in cardiovascular data from COX-2 inhibitor trials--is it a class effect? (2006) (3)
P138 An innovative approach to study design: using electronic medical records to inform the feasibility and design of the novelty study (a novel observational longitudinal study on patients with asthma and/or COPD) (2016) (3)
Pragmatic randomised clinical trials using electronic health records: general practitioner views on a model of a priori consent (2018) (3)
A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients (2019) (3)
The &bgr;-2 agonist debate: is there still a problem? (2013) (3)
Fenoterol and asthma death. (1989) (3)
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma (2021) (3)
Potential risks of using LABAs with ICS therapy. (2009) (3)
Beta-agonist use and death from asthma. (1994) (3)
Venous thromboembolism in medical inpatients--the silent epidemic of neglect. (2005) (3)
Fenoterol and asthma mortality in New Zealand. (1990) (3)
Nebulized beta 2-adrenoceptor agonists do not affect plasma selenium or glutathione peroxidase activity in patients with asthma. (1994) (3)
Optimal starting dose of inhaled corticosteroids in adult asthma: why has it taken so long? (2005) (3)
A feasibility study: association between gut microbiota enterotype and antibody response to seasonal trivalent influenza vaccine in adults (2018) (3)
How to write research papers and grants: 2011 Asian Pacific Society for Respirology Annual Scientific Meeting Postgraduate Session (2012) (3)
Practice patterns and perceptions of Australian and New Zealand anaesthetists towards perioperative oxygen therapy (2019) (2)
Inconsistencies in Cardiovascular Data from COX-2 Inhibitor Trials–is it a Class Effect? (2006) (2)
How Much Asthma can be Attributed to Atopic Sensitization (2008) (2)
Bronchial responsiveness during regular fenoterol therapy. (1991) (2)
Inhaled JAK inhibitor GDC-4379 reduces FeNO in patients with mild asthma (2021) (2)
Correction (2017) (2)
Safety of once-daily QMF149 in patients with persistent asthma (2012) (2)
Asthma prescribing: Where are we headed? (2017) (2)
Enhanced airway sensory nerve reactivity in non-eosinophilic asthma (2021) (2)
Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis (2021) (2)
More options for managing severe asthma in adults. (2020) (2)
The Immunological Mysteries of Tuberculosis. (2019) (2)
End of New Zealand asthma epidemic. (1995) (2)
Discrete choice experiments identifying attributes influencing treatment preference in mild asthma (2019) (2)
A search for biochemical markers of human mast cell activation in vivo. (1987) (2)
Late Breaking Abstract - Open-label trial of budesonide/formoterol reliever therapy in mild asthma (2019) (2)
Head circumference at birth and the development of allergic disease – more questions than answers (2001) (2)
From medical student to junior doctor: The “difficult patient” (2006) (2)
β2-agonists and New Zealand asthma mortality (1991) (2)
Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: a randomised crossover trial (2022) (2)
Searching for the optimal oxygen saturation range in acutely unwell patients (2020) (2)
Inhaled Corticosteroids : Impact on Asthma Mortality (2003) (2)
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccine (2022) (2)
The Vexed Problem of Corticosteroid Toxicity in Asthma: Time for Standardized Assessment. (2021) (2)
Venous thromboembolism in long-distance air travellers (2004) (2)
Protocol for a randomised, single-blind, two-arm, parallel-group controlled trial of the efficacy of rhinothermy delivered by nasal high flow therapy in the treatment of the common cold (2019) (2)
Iconographies supplémentaires de l'article : Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome (2013) (2)
The acute use of oxygen therapy in adults (2017) (2)
Improving the use and interpretation of diagnostic tests in pulmonary embolism. (2006) (2)
Beta agonist use during asthma exacerbations: how much is too much? (2011) (2)
A priori consent within pragmatic randomised controlled trials: a web-based survey of statin use in primary care (2017) (2)
Asthma mortality in Japan: What can be done to bring the rate down? (2001) (2)
Late Breaking Abstract - Which treatable traits matter? Prevalence of treatable traits and risk of exacerbation in a random population sample with asthma (2018) (2)
Has the time come to end use of the blue inhaler? (2021) (2)
RCT of the effect of berryfruit polyphenolic cultivar extract in mild steroid-naive asthma: a cross-over, placebo-controlled study (2017) (1)
What risk do consumers face when seeking medical advice from health food stores? (2011) (1)
Legflow® increases lower-limb venous haemodynamics when seated: A randomised controlled trial (2016) (1)
Legflow® increases lower-limb venous haemodynamics when seated: A randomised controlled trial (2016) (1)
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study. (2022) (1)
Asthma in the anti-inflammatory reliever therapy era. (2020) (1)
Twenty‐five years of Respirology: Advances in asthma (2020) (1)
Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice. (2020) (1)
Authors’ reply to ‘Explaining differential effects of tiotropium on mortality in COPD’ (2013) (1)
IT and medicine (2007) (1)
COVID-19 vaccination and the skin to deltoid MUSCLE distance in adults with diabetes (2022) (1)
Starting beta‐blockers during exacerbations of chronic obstructive pulmonary disease (2018) (1)
Respirology year‐in‐review 2006: Clinical science (2006) (1)
From medical student to junior doctor: the scripted guide to patient clerking (2005) (1)
Management of primary spontaneous pneumothorax: less is more (2020) (1)
An adult asthma assessment and management protocol for use in the emergency department. (2003) (1)
The budesonide/formoterol inhaler as maintenance and reliever therapy in Maori asthmatics (2013) (1)
The association between SpO2 values and mortality--interpret with caution. (2013) (1)
Serum periostin in obstructive airways disease: distribution, relationships, and steroid responsiveness. (2016) (1)
Adult asthma quick reference guides: Trans‐Tasman differences in opinion (2017) (1)
Acetaminophen and Asthma: Spurious Association? (2011) (1)
A randomised controlled trial of topical Kanuka honey for the treatment of eczema (2014) (1)
The Clinical Relevance of Periostin in Asthma (2018) (1)
Balancing the risks and benefits of celecoxib. (2007) (1)
Buteyko pseudoscience. (2004) (1)
Conservative or liberal oxygen therapy for mechanically ventilated adults with acute brain pathologies: A post-hoc subgroup analysis. (2022) (1)
Pilot study of feasibility of a randomised controlled trial of asthma risk with paracetamol versus ibuprofen use in infancy. (2016) (1)
Long-term efficacy of QMF149 in persistent asthma (2012) (1)
The effect of 50% oxygen on PtCO2 in patients with stable COPD, bronchiectasis, and neuromuscular disease or kyphoscoliosis: randomised cross-over trials (2020) (1)
From medical student to junior doctor: care of the deceased patient (2006) (1)
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma (2021) (1)
Oxygen compared to air driven nebulisers for acute exacerbations of COPD: a randomised controlled trial (2017) (1)
From Osler to personalized medicine in obstructive airways disease (2020) (1)
Fenoterol prescribing and asthma severity. (1990) (1)
Arterial hyperoxia and in-hospital mortality after resuscitation from cardiac arrest. (2010) (1)
Fenoterol and fear of flying. (1989) (1)
Fenoterol: confounding again. (1989) (1)
The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals (2004) (1)
SERIES “THE GLOBAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE” #1: Epidemiology and costs of chronic obstructive pulmonary disease (2006) (1)
Asthma exacerbations and inhaled corticosteroids (2004) (1)
Topical kanuka honey for the treatment of nappy rash (2014) (1)
Beta agonists and asthma. (1990) (1)
LONG-ACTING BETA 2-AGONIST DRUGS (2000) (1)
Asthma Research in New Zealand (2000) (1)
Diagnosis and management of adult asthma (2003) (1)
Phenotyping airways disease by cluster analysis in primary care: 6 distinct clusters identified (2014) (1)
Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses (2022) (1)
Intranasal beta-agonist in allergic rhinitis. (2000) (1)
Pragmatic Randomized Controlled Trial of Budesonide/Formoterol Reliever Therapy in Adults with Mild Asthma (2019) (1)
The use of water as a diluent for bronchodilator nebuliser solutions. (1990) (1)
Time trends in fenoterol and asthma deaths: optical illusion or reality check? (1998) (1)
Asthma mortality and over the counter purchase of inhaled beta agonists: REPLY (1992) (1)
Authors’ response to Metzdorf et al (2013) (1)
Assessing PaCO2 In The Emergency Department: Accuracy Of A Transcutaneous Carbon Dioxide Device In Acute Respiratory Disease (2010) (1)
Fenoterol: enough is enough. (1992) (1)
Unsuitability of the Human Erythrocyte as a Model for in Vivo Sodium Transport Activation by Beta2 Adrenergic Agonists (1989) (1)
The localisation of eosinophil major basic protein in the lungs of 64 cases of fatal asthma (1990) (1)
Heart rate variability as a marker of autonomic nervous system activity in young people with eosinophilic and non-eosinophilic asthma (2022) (1)
What variables should inform needle length choice for deltoid intramuscular injection? A systematic review (2023) (1)
How best to share research with study participants? A randomised crossover trial comparing a comic, lay summary, and scientific abstract (2022) (1)
From the authors: (2004) (1)
The duration of anti-inflammatory action of fluticasone furoate (FF) assessed via exhaled nitric oxide (FeNO) in asthmatics following administration of FF/vilanterol (VI) (2017) (1)
P161 A randomised controlled trial of single combination budesonide/formoterol inhaler as maintenance and reliever therapy in asthma patients at risk of severe exacerbations (2013) (1)
Preventing adverse cardiac events (PACE) in chronic obstructive pulmonary disease (COPD): study protocol for a double-blind, placebo controlled, randomised controlled trial of bisoprolol in COPD (2021) (1)
Perspectives of mild asthma patients on maintenance versus as-needed preventer treatment regimens: a qualitative study (2022) (1)
Individualized treatment for asthma (2012) (1)
AUTHORS' REPLY (1989) (0)
Use of antiasthmatic drugs in Australia (1991) (0)
Comparison oftheefficacy ofpreservative free ipratropium bromide andAtrovent nebuliser solution (1988) (0)
A year in review: Respirology 2005 – Clinical science (2006) (0)
AUTHORS' REPLY (1992) (0)
Pulmonary thromboendarterectomy for thromboembolic pulmonary hypertension. (2000) (0)
analysis of the cardioprotective effects of remote ischaemic pre- conditioninginop encardiacsurgery (2012) (0)
Baseline risk for asthma deaths. (1992) (0)
Clinical features of patients hospitalised with COVID-19 from February to October 2020, during the early waves of the pandemic in New Zealand. (2022) (0)
P164 Use of beta-agonists prior to hospital attendance for severe exacerbations of asthma: insights from a randomised controlled trial using electronic monitoring of inhaler use (2013) (0)
THE NEW ZEALAND MEDICAL JOURNAL 13 October 2000 (2000) (0)
Achieving the balance between evidence and simplicity (2020) (0)
BETA -AGONIST USE AND DEATH FROM ASTHMA. AUTHORS' REPLY (1994) (0)
Which traits to target in asthma? Importance of treatable traits varies depending on desired outcome (2019) (0)
International s study o of a asthma a and a allergies iin c childhood ((ISAAC): rationale a and m methods (1995) (0)
Community-based a asthma c care: trial o of a a ""credit c card" a asthma s self-management p plan (1994) (0)
Nebulised salbutamol and magnesium sulphate in acute asthma (2003) (0)
Reply to the letter from Drs Standinger and Haas (1993) (0)
Asthma paradoxes: time for a new approach across the spectrum of asthma severity (2019) (0)
FULL TITLE: EFFICACY OF MICRO-MOBILE FOOT COMPRESSION DEVICE IN INCREASING LOWER LIMB VENOUS BLOOD FLOW SHORT TITLE: FOOT COMPRESSION TO INCREASE LOWER LIMB BLOOD FLOW (2017) (0)
Airway sensory nerve sensitivity in adolescents with eosinophilic and non-eosinophilic asthma (2020) (0)
Maintenance and reliever combination budesonide/formoterol therapy in asthma patients at risk of severe exacerbations: A randomised controlled trial (2013) (0)
FENOTEROL AND ASTHMA MORTALITY (1989) (0)
Family size, infection and atopy: the first decade of the "hygiene hypothesis" (2000) (0)
3. THE USE OF INHALED ANTI-INFLAMMATORY THERAPY IN THE MANAGEMENT OF ASTHMA (1993) (0)
P226 Combined analysis of two randomized controlled trials of budesonide/formoterol reliever therapy in adults with mild asthma (2019) (0)
LETTERS TO THE EDITOR study of prescribed fenoterol and death from asthma in (0)
Has the role of atopy in the development of asthma been over‐emphasized? (0)
Re:Oxygen therapy in COPD (2017) (0)
A study of the potential role of sleep disorders in new zealand road traffic accidents (2001) (0)
From the authors: (1991) (0)
management of severe asthma in adults in hospital Asthma exacerbations · 5: Assessment and (2007) (0)
Local anaesthesia for fibreoptic (0)
Exacerbation burden in mild asthma: Evidence from the NOVELTY study (2020) (0)
Extrapulmonary effects of fenoterol and salbutamol in normal subjects. (1994) (0)
Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID‐19 in New Zealand (2021) (0)
Enhanced sensory nerve reactivity in non-eosinophilic asthma (2021) (0)
Perioperative oxygen administration in patients undergoing major non-cardiac surgery under general anaesthesia in Australia and New Zealand. (2023) (0)
THE ICS/FORMOTEROL RELIEVER THERAPY REGIMEN IN ASTHMA: A REVIEW. (2023) (0)
Advice for the management of asthma – health food stores vs. community pharmacies (2010) (0)
Long-Acting ß2-Agonist Drugs (1999) (0)
Asthma severity and fenoterol prescribing. (1991) (0)
Effect of smoking status on the efficacy of the SMART regimen in high risk asthma – Reply (2016) (0)
LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY (2022) (0)
Preventer Therapy for Mild Asthma: A Qualitative Study of Patients' Treatment Experiences (2020) (0)
8 Asthma Mortality and Beta Agonists : The international experience including Japan(3 わが国のβ_2刺激薬MDIと喘息死) (2000) (0)
USE OF ANTIASTHMATIC DRUG IN AUSTRALIA. AUTHOR'S REPLY (1991) (0)
attacks of asthma . Case-control study of salmeterol and near-fatal (1998) (0)
An Approach to the Management of High Risk Asthmatic Patients (2012) (0)
Venous Thromboembolism in Medical Inpatients–-the Silent Epidemic of Neglect (2005) (0)
AUTHORS' REPLY (1990) (0)
Letter from New Zealand (2022) (0)
INTRODUCTION: Avian influenza: From basic biology to pandemic planning (2008) (0)
Chronic Airways Assessment Test: psychometric properties in patients with asthma and/or COPD (2023) (0)
Stability of inflammatory phenotypes in asthma (0)
Panel: Association between asthma and exposure to paracetamol (2009) (0)
corticosteroids in symptomatic asthma salmeterol versus higher doses of inhaled Moderate dose inhaled corticosteroids plus (2008) (0)
Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation. (2022) (0)
Reply: Letters to the Editor (2012) (0)
Efficacy of As-needed Use of Albuterol-Budesonide in Patients With Moderate-to-Severe Asthma Who Are Adherent to Maintenance Therapy (2023) (0)
Adrenaline (epinephrine) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis (2021) (0)
From medical student to junior doctor: the night shift (2006) (0)
Routine oxygen therapy in myocardial infarction--primum non nocere (2017) (0)
Anti-androgen contraceptive pills and higher risk of venous thromboembolism. (2016) (0)
New Zealand asthma guidelines updated. (2017) (0)
Factors associated with physician assessment of severity of asthma or COPD in NOVELTY (2020) (0)
Effect oforal terfenadine onthebronchoconstrict or responsetoinhaled histamine andadenosine 5'-monophosphate innon-atopic asthma (2017) (0)
PRS68 The Humanistic Burden of Mild Asthma: Evidence from the Novelty Study (2020) (0)
A selfmanagement plan in the treatment of adult asthma Methods SUBJECTS (0)
Study protocol for the Randomised Evaluation of Active Control of Temperature vs. ORdinary temperature management (REACTOR) trial. (2017) (0)
Authors' response: hyperoxia in acute asthma (2012) (0)
Venous thromboembolism in long-distance air travellers. Authors' reply (2004) (0)
What do patients want? Preferences for two asthma regimens in mild/moderate asthma (2019) (0)
Vitamin D and asthma: a case to answer. (2017) (0)
Reply (2012) (0)
FENOTEROL AND ASTHMA MORTALITY. AUTHORS' REPLY (1998) (0)
Occupational Exposures in Relation to Obstructive Lung Disease in a New Zealand Population Cohort (2007) (0)
From medical student to junior doctor: rules of confidentiality (2006) (0)
An audit of a marae-based health centre management of COVID-19 community cases in South Auckland. (2022) (0)
ICS/formoterol maintenance and reliever therapy: how far beyond asthma? (2023) (0)
Letter in response to Tashkin et al: limited generalisability of uplift findings to clinical practice (2013) (0)
SUITABILITY OF AUSTRALIAN ELECTRONIC MEDICAL RECORDS TO GUIDE THE DESIGN OF THE NOVELTY STUDY (2017) (0)
From medical student to junior doctor: Working outside the box (2006) (0)
Reply to Boulet and Nair: Inhaled Corticosteroids and Adult Asthma (2019) (0)
Strength of association between comorbidities and asthma: a meta-analysis (2023) (0)
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials (2022) (0)
Clinical and epidemiological characteristics of COVID-19 in Wellington, New Zealand: a retrospective, observational study. (2021) (0)
Estimating the prevalence of drawing in clinical practice among kiwi doctors (2022) (0)
Inhaled Corticosteroids in Asthma: When Less Is More. (2023) (0)
Reply (2004) (0)
Prototype ORACLE Score Validation in NOVELTY: Predicted versus Observed Asthma Exacerbation Rates (2022) (0)
ThoraxAbstract 148..148 (2013) (0)
From medical student to junior doctor: Clinical pharmacology to prescribing responsibility (2006) (0)
Thesite ofdisruption ofthebronchial epithelium inasthmatic andnon-asthmatic subjects (1992) (0)
When should a longer needle be used for intramuscular injection in obese patients? A combined analysis of New Zealand data. (2023) (0)
From medical student to junior doctor: accepting the responsibility of informed consent (2006) (0)
Over-the-counter Dispensing: Widening Access to Inhaled Corticosteroid/Formoterol Reliever Therapy (2022) (0)
Correction: Prophylaxis in healthcare workers during a pandemic: a model for a multi-centre international randomised controlled trial using Bayesian analyses (2022) (0)
Every action matters, every bit of warming matters (2023) (0)
P201 To what extent does the prototype ORACLE scale predict treatment benefits? Predicted versus observed impact of anti-inflammatory treatments (2021) (0)
Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study (2023) (0)
From medical student to junior doctor: how to approach the interpretation of investigations (2005) (0)
Cannabis use and risk of lung cancer : a case-control study. Commentary (2008) (0)
3:45 PM Abstract No. 156 ■ FEATURED ABSTRACT The Lutonix ® Global DCB Registry real-world patients with below-the-knee disease: interim 6-month outcomes (2018) (0)
Determination of oxygen saturation compared to a prescribed target range using continuous pulse oximetry in acutely unwell medical patients (2021) (0)
Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial (2021) (0)
From medical student to junior doctor: an A to Z guide (2004) (0)
Albuterol-budesonide pressurized metered dose inhaler in patients with mild-to-moderate asthma: results of the DENALI double-blind randomized controlled trial. (2023) (0)
Risk factors for corticosteroid- and antibiotic only-treated asthma attacks in the NOVELTY cohort (2022) (0)
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials (2023) (0)
Is tezepelumab the ubiquitous biologic for severe asthma? (2023) (0)
Development of a Prototype ORACLE Web-app to Predict Treatment Benefits of Type-2 Targeted Anti-Inflammatory Treatment in Asthma (2022) (0)
Skin-to-deltoid-muscle distance at three recommended sites for intramuscular vaccination in a population with obesity: an observational study. (2023) (0)
Qualitative Research on Patient Experiences of As-Needed Budesonide/Formoterol for Treatment of Mild Asthma (2019) (0)
Abstracts of the Thoracic Society of Australia & New Zealand and the Australian & New Zealand Society of Respiratory Science 2012 Annual Scientific Meetings. March 30-April 4, 2012. Canberra, ACT, Australia. (2012) (0)
Asthma exacerbations and inhaled corticosteroids. Authors' reply (2004) (0)
Factors associated with exacerbations in patients with COPD: NOVELTY study (2020) (0)
From the authors (2008) (0)
P165 The reliability and performance of electronic monitors of inhaler use in a real world asthma clinical trial (2013) (0)
Clinical factors associated with baseline blood eosinophils among patients with asthma or COPD: NOVELTY study (2020) (0)
ASSESSMENT OF US ELECTRONIC MEDICAL RECORDS TO GUIDE FEASIBILITY AND DESIGN OF THE NOVELTY STUDY (2017) (0)
Systematic review of the comparison between adrenaline (epinephrine) and selective ß2-agonist in the setting of adults or children with acute asthma (2020) (0)
A breath of fresh AIR: reducing the carbon footprint of asthma (2022) (0)
Manegement Approaches To Reduce Asthma Mortality (2000) (0)
The use of assessment and management protocols for asthma in the emergency department (2001) (0)
Freedom of debate and legal threats. (2000) (0)
Oxygen therapy in the breathless patient. Author's reply (2008) (0)
Inappropriate use of inhaled beta agonists in asthma. (1990) (0)
Efficacy of a 3% Kānuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial (2022) (0)
LATE-BREAKING ABSTRACT: Impact of demographics and comorbidities on periostin and eosinophil levels (2016) (0)
Asthma and the j8 agonist debate A cohort analysis of excess mortality in asthma and the use of inhaled P agonists Regular v as-needed inhaled salbutamol in asthma control (0)
The New Zealand respiratory health survey- rationale, methodology and response rate (2013) (0)
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma (2013) (0)
Hyperbaric oxygen chamber at Devonport. (1990) (0)
A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol. (1990) (0)

This paper list is powered by the following services:

Other Resources About Richard Beasley

en.wikipedia.org

What Schools Are Affiliated With Richard Beasley ?

Richard Beasley is affiliated with the following schools: